Sodium-glucose cotransporter-2 inhibitors improve liver enzymes in patients with co-existing non-alcoholic fatty liver disease: a systematic review and metanalysis
Waseem Amjad(Allama Iqbal Medical College), Aijaz Ahmed(Stanford University), Mirrah Mumtaz(Albany Medical Center Hospital), Waqas Qureshi(Houston Methodist), Shakeel Jamal(Central Michigan University), Brittany B. Dennis(McMaster University), Adnan Malik(Loyola University Medical Center), Faisal Jaura(Wayne State University), Rabbia Haider(Nishtar Medical College and Hospital)
Cited by 8
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Public Availability of Published Research Data in High-Impact Journals
|PLoS ONE|2011|378
Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies
|PLoS Medicine|2018|234
Restarting Anticoagulation and Outcomes After Major Gastrointestinal Bleeding in Atrial Fibrillation
|The American Journal of Cardiology|2013|217
Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation
|Circulation|2015|209